Selecta生物科学

SELB NASDAQ
2.175
-0.035
-1.58%
交易中 15:34 06/18 EDT
开盘
2.210
昨收
2.210
最高
2.370
最低
2.155
成交量
14.15万
成交均量(3M)
38.71万
52周最高
16.55
52周最低
1.410
换手率
0.32%
市值
9,741.40万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Selecta生物科学 SELB股票价格,Selecta生物科学股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company using its synthetic vaccine particle (SVP) technology to discover and develop targeted therapies that are designed to modulate the immune system to treat rare and serious diseases. The Company is engaged in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its product candidates are in various stages of clinical and preclinical development. Its SVP technology encapsulates an immunomodulator in biodegradable nanoparticles to induce antigen-specific immune tolerance to mitigate the formation of anti-drug antibodies (ADAs) in response to life-sustaining biologic drugs. The Company's lead product candidate, SEL-212, is a combination of a therapeutic enzyme and its SVP technology designed to be the biologic treatment for gout.
展开 >

最近浏览

名称
价格
涨跌幅